Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: a three years’ following-up study-Reference-Cited by-同舟云学术

Possible predictors for relapse from etanercept discontinuation in ankylosing spondylitis patients in remission: a three years’ following-up study

Published:2017-08-07 Issue:1 Volume:37 Page:87-92
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Zhao Minjing,Zhang Pingping,Fang Linkai,Luo Zhongxing,Gu Jieruo,Lin Zhiming

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-017-3763-x/fulltext.html

Reference23 articles.

1. Braun J, Sieper J (1996) The sacroiliac joint in the spondyloarthropathies. Curr Opin Rheumatol 8:275–287

2. de Vlam K, Mielants H, Cuvelier C et al (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865

3. Braun J, de Keyser F, Brandt J et al (2001) New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 13:245–249

4. Gorman JD, Sack KE, Davis JC Jr (2002) Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346:1349–1356

5. Baji P, Pentek M, Szanto S et al (2014) Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis. Eur J Health Econ 15(Suppl 1):S45–S52

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis;Nature Reviews Rheumatology;2023-10-06

2. Potential for sustaining remission in ankylosing spondylitis patients upon netakimab discontinuation;Meditsinskiy sovet = Medical Council;2023-07-24

3. Décroissance ou arrêt des traitements de fond biologiques dans la spondyloarthrite axiale : revue de la littérature;Revue du Rhumatisme;2023-05

4. Tapering or discontinuation of biological disease-modifying antirheumatic drugs in axial spondyloarthritis: A review of the literature and discussion on current practice;Joint Bone Spine;2023-01

5. Tumour necrosis factor inhibitor tapering in patients with ankylosing spondylitis at low disease activity: factors associated with flare;Therapeutic Advances in Musculoskeletal Disease;2021-01